AlphaStocks

AZTA vs DHR

As of Sep 20, 2026, Azenta (AZTA) scores 6.6/10 and Danaher (DHR) 4.6/10 on AlphaStocks' five-model composite, so AZTA scores higher. DHR trades 52% above its model fair value.

AZTA

Azenta, Inc.

6.6

Consider Buy

$33.25

DHR

DANAHER CORP /DE/

4.6

Weak

$211.77

AZTA vs DHR: Which is the Better Investment?

Azenta, Inc. (AZTA) scores 6.6/10 while DANAHER CORP /DE/ (DHR) scores 4.6/10 on AlphaStocks' composite model. Azenta, Inc. has the higher composite rating of Consider Buy.

This comparison is algorithmically generated and is not financial advice.

MetricAZTADHR
Scores & Fundamentals
Composite Score6.6/104.6/10
RatingConsider BuyWeak
Price$33.25$211.77
P/E Ratio42.0
ROE-3.3%7.0%
Market Cap$2B$151B
Fair Value$139.67
Dividend Yield0.6%
Sector Rank#23 of 168#125 of 168
Model Verdicts
PiotroskiAttractiveAttractive
BuffettNeutralNeutral
GrahamNeutralNeutral
LynchLimited DataNeutral
GreenblattLimited DataNeutral
View full AZTAanalysis →View full DHRanalysis →

Related comparisons

Compare any two stocks →

AZTA vs DHR: Which Stock Scores Higher?

Azenta, Inc. (AZTA) and DANAHER CORP /DE/ (DHR) are both in the Health Care sector. AZTA currently leads with a composite score of 6.6/10 (Consider Buy) compared to DHR's 4.6/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer